OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

GENMAB AS DK 1/  DK0010272202  /

Hannover
2024-05-28  8:08:52 AM Chg. +2.50 Volume Bid6:01:17 PM Ask6:01:17 PM Market Capitalization Dividend Y. P/E Ratio
260.50EUR +0.97% 0
Turnover: 0.00		 257.70Bid Size: 20 260.60Ask Size: 20 17.13 bill.EUR - -
GlobeNewswire 05-21 Genmab Completes Acquisition of ProfoundBio
GlobeNewswire 05-02 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 04-30 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...
GlobeNewswire 04-03 Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
GlobeNewswire 02-14 Genmab Announces Initiation of Share Buy-Back Program
GlobeNewswire 02-14 Genmab Publishes 2023 Annual Report
GlobeNewswire 2023-11-09 Major Shareholder Announcement
GlobeNewswire 2023-11-08 Major Shareholder Announcement
GlobeNewswire 2023-11-07 Genmab Announces Financial Results for the First Nine Months of 2023
GlobeNewswire 2023-10-17 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2023
GlobeNewswire 2023-09-25 Genmab Announces European Commission Approval of TEPKINLY® (epcoritamab) for Adults with Relapsed or...
GlobeNewswire 2023-09-04 Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improve...
GlobeNewswire 2022-02-24 Notice to Convene the Annual General Meeting of Genmab A/S
GlobeNewswire 2022-02-16 Genmab Publishes 2021 Annual Report
GlobeNewswire 2022-01-25 Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2021
GlobeNewswire 2021-11-10 Genmab Announces Financial Results for the First Nine Months of 2021
GlobeNewswire 2021-11-04 Genmab Improves its 2021 Financial Guidance
GlobeNewswire 2021-10-19 Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2021
GlobeNewswire 2021-09-21 Capital Increase in Genmab as a Result of Employee Warrant Exercise
GlobeNewswire 2021-09-20 Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previous...
GlobeNewswire 2021-08-11 Genmab Announces Financial Results for the First Half of 2021
GlobeNewswire 2021-07-21 Major Shareholder Announcement
GlobeNewswire 2021-07-21 Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2021
GlobeNewswire 2021-06-22 Genmab Announces that Janssen has Received European Marketing Authorizations for DARZALEX® (daratumu...
GlobeNewswire 2021-05-21 Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab...